1. Context
2. Isolation from Human Clinical Specimens
| Variables | Staphylococcus aureus | Staphylococcus argenteus (MSHR1132T) | Staphylococcus schweitzeri | Staphylococcus singaporensis (SS21T) | Staphylococcus roterodami |
|---|---|---|---|---|---|
| Pigmentation | + | -1 a | +2 b | - | |
| β-Hemolysis | + | + | + | + | + |
| Arginine Dihydrolase | + | + | + | + | + |
| Acetoin Production | + | ||||
| Alkaline Phosphatase | + | + | + | + | + |
| Catalase | + | + | + | + | + |
| Coagulase | + | + | + | + | + |
| Nitrate Reduction | + | + | + | ||
| Ornithine Decarboxylase | - | - | |||
| L-Pyrrolidonyl Arylamidase | + | + | + | + | |
| Urease | d c/- | - | - | + | - |
| Hydrolysis of Esculin | - | ||||
| Resistance to Novobiocin | - | - | - | - | |
| Resistance to Polymixin B | + | + | + | + | |
| β-Galactosidase | - | - | - | - | |
| β-Glucosidase | + | - | - | ||
| β-Glucuronidase | - | - | - | - | |
| L-Arabinose | - | ||||
| D-Cellobiose | - | ||||
| Maltose | + | + | + | + | + |
| D-Mannitol | + | + | + | + | + |
| D-Mannose | + | + | + | + | + |
| Raffinose | - | - | - | - | - |
| D-Trehalose | + | + | + | + | + |
| Sucrose | + | + | + | + | + |
| D-Turanose | + | ||||
| D-Xylose | - | - | - | - | - |
| D-Glucose | + | ||||
| D-Fructose | + | ||||
| D-Galactose | + | + | - | + | |
| Lactose | - | - | - | + | + |
| Growth in 6.5 % NaCl | + | + | + | + | |
| Ref. | (4, 35) | (35) | (35, 37) | (38) | (14) |
a Positive for 11 to 89% of strains.
b Creamy white appearance.
c Yellowish-pigmented, nucA gene was positive in all of species.
3. Food Specimens
4. Animal Specimens
5. Phenotypic Identification
6. Molecular Identification
| Organism | Staphylococcus argenteus MSHR1132 T | Staphylococcus aureus 502A | Staphylococcus roterodami Zoo-28 | Staphylococcus schweitzeri DSM 28300 T |
|---|---|---|---|---|
| S. argenteus MSHR1132 [T] | - | 87.62 (84.55) | 93.47 (87.04) | 92.03(86.41) |
| S. aureus 502A | 87.41 (85.98) | - | 87.85 (84.39) | 88.69 (86.05) |
| S. roterodami Zoo-28 | 92.82 (87.55) | 87.81 (81.67) | - | 92.74 (85.00) |
| S. schweitzeri NCTC13712 [T] | 91.82 (87.40) | 88.72 (86.13) | 92.83 (86.83) | - |
a Genome sequence of type strain S. singaporensis was not available in Genebank database.
7. Multilocus Sequence Typing
8. Clinical Diseases, Virulence Factors, Antibiotic Resistance, and Epidemiology
| Bacterium | Common Resistant Antibiotics | Common Susceptible Antibiotics | Resistance Genes |
|---|---|---|---|
| Staphylococcus argenteus | Penicillin (with/without blaZ), tetracycline (with/without tet genes), gentamicin, clindamycin, erythromycin, fusidic acid, ampicillin, daptomycin | More susceptible than S. aureus; lower antibiotic resistance overall | mecA (variable prevalence), SCCmec type IV (rare), blaZ, tet genes |
| S. schweitzeri | No reported resistance | Susceptible to all tested antibiotics | No known resistance genes |
| S. singaporensis | One isolate resistant to gentamicin | Susceptible to penicillin, mupirocin, oxacillin, erythromycin, clindamycin, fusidic acid, ciprofloxacin, minocycline, linezolid, trimethoprim-sulfamethoxazole, teicoplanin, quinupristin-dalfopristin, vancomycin | No known resistance genes |
| S. roterodami | Resistant to polymyxin B | Susceptible to cefoxitin, benzylpenicillin, oxacillin, gentamicin, tobramycin, ciprofloxacin, levofloxacin, erythromycin, clindamycin, linezolid, teicoplanin, vancomycin, tetracycline, fosfomycin, nitrofurantoin, fusidic acid, mupirocin, rifampicin, trimethoprim-sulfamethoxazole | No known resistance genes |
| Country | Year | Type of Study | Sample Type | Total Sample | Values | Identification Method | Bacteria Species | Ref. | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Sequence-based/ Conventional PCR Methods | Band-based Methods | MALDI-TOF | ||||||||
| Thailand | 2016 | Prospective cohort observational study | Sepsis (abscesses n = 163, blood n = 115, bone or arthocentesis n = 21, body fluids, biliary tract and cerbrospinal fluid n = 7, pus from implanted surgical hardware n = 3, pus from spaces such as sinuses and inner ear n = 2) | 311 | 58 (19) | MLST | PFGE | S. argenteus | (24) | |
| Japan | 2017 | Case study | Fecal specimens, food, table, workbench, and empty lunch boxes | 10 | 10 | WGS, MLST | S. argenteus | (40) | ||
| Japan | 2018 | 2 case study | Fecal specimens, food samples, and swabs of cooking utensils | 51 | 36 | MLST | PFGE | S. argenteus | (40) | |
| Gabon | 2016 | Research article | Faucal specimens of wild-living apes (gorilla) | 1 | - | MLST | MALDI-TOF MS | S. argenteus | (46) | |
| Japan | 2020 | Retrospective observational cohort study | Blood culture | 21 | 2 (1) | MLST | S. argenteus | (23) | ||
| Thailand | 2015 | Cohort | Invasive infection (Blood culture) | 246 | 10 (4.1) | MLST | S. argenteus | (18) | ||
| Myanmar | 2017 | Nasal swab (food handlers) | 563 | 5 (4.5) (in 110 carrier) | MLST | S. argenteus | (105) | |||
| Taiwan | 2018 | Retrospective study | Blood culture | 915 | 97 | MLST | MALDI-TOF MS | S. argenteus | (25) | |
| Thailand | 2019 | Original article | Pus (rabbits) | 67 (19 bacteria isolates) | 3 | MLST | MALDI‐TOF MS. | S. argenteus | (20) | |
| Gabon | 2021 | An in vitro study | Monkeys (n = 38), bats (n = 16), humans (n = 3) and gorilla (n = 1) | 156 | 58 | MLST, WGS | S. schweitzeri | (50) | ||
| Nigeria | 2020 | Fomites samples (currency note, computer keyboard) | 239 | 2 | MLST, Wholegenome sequencing | MALDI-TOF MS | S. schweitzeri | (106) | ||
| Nigeria | 2018 | Original article | Fecal samples from E. helvum | 250 samples (53 isolates) | 11 (14) | MLST | MALDI-TOF MS | S. schweitzeri, S. argenteus | (44) | |
| Gabon | 2017 | Short communication | Pharyngeal swabs (Bat) | 133 | 2 (4) | PCR, MLST | MALDI-TOF MS | S. schweitzeri | (49) | |
| Côte d’Ivoire, Gabon, Congo | 2014 | Cross-sectional study | Anterior nares and the pharyngeal mucosa (human and monkey) | Human (1288) and animal (698) | 24 | PCR, MLST | S. schweitzeri | (51) | ||
| United Kingdom | 2021 | Molecular epidemiology case-study | Nasal and throat swab RM recruits) | 1012 | 6 (4 recruits) | WGS, MLST | S. argenteus | (99) | ||
| Japan | 2019 | Clinical specimens: Sputum (6), pharyn× (2), nasal discharge (2), stool (4), skin and abscess (3), urine (2), vaginal discharge (2), ear discharge (1), blood ( 1), and subdural abscess (1) | 23 patients | 24 | PCR, MLST | MALDI-TOF MS | S. argenteus | (21) | ||
| Thailand | 2017 | Invasive infection | 68 | WGS, MLST, PCR | S. argenteus | (100) | ||||
| Denmark | 2017 | Skin and soft tissue infection, wounds, the ear, the nose | 25 | WGS, MLS, PCR | S. argenteus | (19) | ||||
| Sweden | 2019 | Throat swab, perineum, wound, abces, eczema | 16 | WGS | PFGE | MALDI-TOF MS | S. argenteus | (104) | ||
| Belgium | 2016 | Retrospectively study | Clinical laboratories, nasal samples | 1650 | 3 (0.16) | MLST and SCCmec typing | S. argenteus | (101) | ||
| China | 2016 | Short communication | Food products, healthy humans, or hospital infections | 839 | 6 | MLST | S. argenteus | (36) | ||
| United Kingdom | 2021 | Original article | Human, Pig, Gorilla | 132 | MLST, CRISPRCasFinder web-server | S. argenteus | (47) | |||
| France | 2020 | Case study | Prosthetic-joint infection | 1 | WGS | S. argenteus | (84) | |||
| Sweden | 2020 | Short Research Communication | Prosthetic-joint infection | 1 | WGS | MALDI-TOF MS | S. argenteus | (87) | ||
| North American | 2021 | Original article | Clinical samples (sterile sites, 11 from nonsterile sites, and 4 from surveillance screens) | 22 | WGS, 16S rRNA gene analysis | MALDI-TOF MS | S. argenteus | (37) | ||
| Singapore | 2021 | Retrospective cohort study | Clinical and screening samples | 43 | 37 | WGS, MLST | S. argenteus, | (38) | ||
| Singapore | 2021 | Retrospective cohort study | Clinical and screening samples | 43 | 6 | WGS, MLST | S. singaporensis sp. | (38) | ||
| Indonesia | 2021 | Foot wound | 1 | 16S phylogeny, MLST | MALDI-TOF MS | S. roterodami sp. | (14) | |||
| Gabon | 2016 | Cross-sectional study | Human throat swabs, skin lesions | 103 | 3 (2 from school children) | MLST | S. schweitzeri | (107) | ||
| China | 2020 | Retail foods (4300 samples) | 1581 | 114 | MLST | S. argenteus | (42) | |||
| United States | 2020 | Case report | Hemodialysis catheter | 1 | MALDITOF MS | S. argenteus | (18) | |||
| Taiwan | 2020 | Blood | 96 | MLST | PFGE | MALDI-TOF MS | S. argenteus | (26) | ||
| Myanmar | 2019 | Research article | Nasal isolates of healthy food handlers (563), clinical isolates (wound swab, pus, and blood) | 144 + 137 | 6 | MLST | S. argenteus | (108) | ||
| Japan | 2020 | Case report | Conjunctival scraping | 1 | Whole-genome sequence, MLST | MALDITOF MS | S. argenteus | (89) | ||
| Japan | 2021 | Clinical specimens | 82 | 3 (0.66) | MALDI-TOF MS | S. argenteus | (103) | |||
Abbreviations: RM, royal marines; WGS, whole-genome sequencing; PCR, polymerase chain reaction; MLST, multilocus sequence typing.
